Medline Inc. announced the pricing of an upsized secondary offering of 72,554,594 Class A common shares by selling stockholders affiliated with Blackstone, Hellman & Friedman, and Abu Dhabi Investment Authority at $37 per share. The selling stockholders also granted underwriters a 30-day option to purchase an additional 10,883,189 shares. Medline itself is not selling shares and will not receive proceeds from this offering, which is expected to close on May 28, 2026. This move allows major shareholders to liquidate part of their holdings while Medline continues its operations without dilution of its own shares.
Liminatus Pharma received a delisting notice from Nasdaq due to failure to meet minimum market value requirements for its listed securities and publicly held shares. The company was given until May 18, 2026, to regain compliance but did not meet the ...
Roblox's recent implementation of age verification has temporarily slowed daily active users and engagement, especially in its high-value US and Canada market. This adjustment, along with the upcoming launch of kids' accounts, is aimed at regulatory ...
American Coastal Insurance (ACIC) is rated a buy due to its strategic exit from personal insurance lines, which improves its scalability and risk profile. The company's Q1 2026 results showed stable profit margins with a 27% net income margin and str...
Audiencerate Ltd has named Riccardo Fabbri as its new Chief Technology Officer, marking the start of an AI-driven expansion phase for its platforms serving Italian SMEs and global media agencies. Fabbri, with over 20 years of experience in software a...
Google has expanded its AI-powered creative platform, Google Flow, and its music counterpart globally, introducing the Gemini Omni Flash multimodal AI model. This model can generate content across text, images, audio, and video, simulating real-world...
